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Abstract
Background: Typical analysis of time-series gene expression data such as clustering or graphical models cannot
distinguish between early and later drug responsive gene targets in cancer cells. However, these genes would
represent good candidate biomarkers.
Results: We propose a new model - the dynamic time order network - to distinguish and connect early and later
drug responsive gene targets. This network is constructed based on an integrated differential equation. Spline
regression is applied for an accurate modeling of the time variation of gene expressions. Then a likelihood ratio
test is implemented to infer the time order of any gene expression pair. One application of the model is the
discovery of estrogen response biomarkers. For this purpose, we focused on genes whose responses are late when
the breast cancer cells are treated with estradiol (E2).
Conclusions: Our approach has been validated by successfully finding time order relations between genes of the
cell cycle system. More notably, we found late response genes potentially interesting as biomarkers of E2 treatment.
Background
Breast cancer represents a major public health issue since
it comprises 22.9% of all cancers in women and it is an
important cause of death [1]. Some breast cancers are
sensitive to hormones such as estrogen (E2) [2]. Thus it
is possible to treat these cancers by blocking the effects
of these hormones, using for instance tamoxifen [3]. The
discovery of biomarkers of the response to drugs is an
important task in medical research because it helps know
if a drug is effective for a specific patient and how it is
metabolized by his organism. Biomarkers play thus an
important role in personalized medicine, such as in the
choice of the most relevant treatment.
Biomarkers often refer to proteins measured in the
blood whose concentrations reflect the presence or the
severity of the disease. In the case of estrogen treatment,
biomarkers can be seen as parameters reflecting the
effects of the drug on the patient. The biomarkers of hor-
mone therapy of the breast cancer is not well developed.
For instance, although tamoxifen’s pharmacology
mechanism is well known, its clinical biomarker is not
well established yet. Understanding the cascade of estro-
gen signaling pathway is the key to study the potential
biomarkers.
Gene expression-based biomarker discovery has
demonstrated efficiency for breast cancer [4,5]. Standard
methods rely on computing correlations between gene
expressions and drug treatment status. Simple statistical
procedures are used such as t-tests to assess the signifi-
cance of over- or under-expressions of genes before and
after treatment in steady-state analysis [6]. Clustering has
also been successfully used for revealing particular pat-
terns of expression [7].
Unfortunately standard methods might fail to reveal
key biomarkers, since they do not take into account the
temporal aspect of gene expression and the complex net-
work of gene regulation. To tackle this issue, the analysis
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of time series data through dynamic networks represents
efficient alternatives [8]. In this context, three main
approaches can be distinguished: dynamic Bayesian net-
works, information-theoretic networks and ordinary dif-
ferential equations. Dynamic Bayesian networks (DBNs)
have been successfully applied to infer causal gene net-
works [9,10]. Conditional independences encoded in
DBNs guarantee to infer direct relations between genes.
The second approach consists in inferring the structure
of dependences through an information-theoretic frame-
work [11,12]. Most notably, the data processing inequal-
ity principle helps discard the majority of indirect
dependences without involving time consuming algo-
rithms such as those for DBNs. The last method relies on
ordinary differential equations (ODEs) [13,14]. In this
method, changes of gene expression are related to each
other through a system of differential equations. Most
notably, this method accurately and explicitly models the
continuous time aspect of gene expression. Recently a
combination of ODEs and DBNs has been proposed for
taking into account both causal discovery (DBNs) and
accurate modeling (ODEs) of gene expression [15].
Late response genes might represent relevant biomar-
kers because they are more stable over the time. Our
approach relies on this biological aspect of biomarker
discovery. To identify late response genes, we propose a
new model based on a dynamic time order network
(DTON). The model interpretation is simple and intui-
tive: it reflects which genes express in the early times and
which ones in the late times after the hormone treat-
ment. The DTON is constructed based on an integrated
differential equation. Spline regression is applied for an
accurate modeling of the time variation of gene expres-
sions. A likelihood ratio test is implemented to infer the
time order of any gene expression pair. The advantages
of this modeling approach are numerous: (i) closed-form
expressions of ODEs, (ii) accurate modeling of the time
series data by using spline regression and by integrating
differential equations, and (iii) model learning involving
simple regressions quick to compute and only a few para-
meters have to be estimated. The method has been vali-
dated by successfully finding time order relations
between genes of the cell cycle system. Most importantly,
we found late response genes as candidate biomarkers of
E2 treatment.
This paper is organized as follows. Section Materials and
methods first describes experiments and data preproces-
sing. Late response genes are defined and discussed. Then
the dynamic time order network and its model learning
are presented. It is described how dynamic time order
relations between genes are inferred through a likelihood
ratio test. The next section illustrates our method on real
data analysis. Our model is validated with the well-known
cell cycle system. Late response genes of E2 treatment are
discovered. Finally, the last section concludes and points
out promising perspectives.
Materials and methods
Experiment and data preprocessing
The gene expression data come from estrogen stimu-
lated ZR_75_1 cells. G0 - G1 synchronization cells were
treated with 10-8 M of 17 b - estradiol (E2). Then RNA
was extracted from the cells before (0) or after 1, 2, 4, 6,
8, 12, 16, 20, 24, 28 and 32 hours of stimulation. For
more details, the reader is referred to the original study
[16]. There are 48702 probes in the original study and
some of them are duplicated. Duplicated probes are
averaged. Then only highly differentially expressed genes
are considered through the following method. Standard
deviation and mean were computed for each mRNA. A
gene is considered as not differentially expressed if its
standard deviation over its mean is small. At this point,
we chose 0.15 as threshold. Finally, we only kept 5003
genes with high variation of their expression. The loga-
rithmic concentration ratio (LCR) at every time point is
used. Let Ct denotes the concentration at time point t
for a gene, then the LCR at time point t would be log
Ct
C0
. The LCR indicates how much the concentration
increases or decreases from the concentration at the
first time point. In order to unify the variance for differ-
ent genes, we standardized the LCRs at each time point.
Late response gene
In breast cancer cells, Cicatiello et al. [16] showed that
all the major time dependent gene expression profile
clusters follow two major patterns: (i) go up or down,
then stay flat; and (ii) go up or down first, stay flat, then
go down or up, respectively. These patterns can be cap-
tured by a natural cubic spline function divided in three
parts using two knots. The early response genes are
thus defined as either up- or down-regulated genes
before 5.333 hours, following E2 stimulation. The late
response genes are defined as either up- or down-regu-
lated genes after 17.333 hours. The time points 5.333
hours and 17.333 hours represent the 33th and 67th
percentiles of the sampling time points.
Biologically, we favor late response genes because of
their clinical implications. To check whether a drug
works in human, i.e. inhibiting or simulating the target,
one or multiple reliable biomarkers are useful to indi-
cate the drug effects. An early response gene may not
be predictive for the long term effect of the drug. It is
always desirable to use a biomarker that can predict a
sustainable effect of the drug. Therefore, a late response
gene represents a better biomarker than an early
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response one. In our dataset, responsive genes after
17.333 hours following E2 treatment are likely to be the
best biomarkers.
The dynamic time order relationship
Let f1(t) and f2(t) represent the LCR curves of two genes
G1 and G2 over the time t, as depicted in Figure 1a.
Suppose G1 and G2 have a dynamic time order relation
such that the expression of G2 is later than the one of
G1. This relation is denoted as G1 ® G2. Then the
changing rate of G2 should be related to the LCR of G1
and itself [8]. The model is an ODE:
df2(t)
dt
= k1 f1(t) + k2 f2(t). (1)
In Equation (1), df2(t)
dt
represents the changing rate of
G2 expression. Alternatively, Equation (1) can be
expressed by integration:
f2(t) = k1 F1(t) + k2 F2(t). (2)
In Equation (2), F1(t) and F2(t) represent the cumula-
tive expression of G1 and G2. The integration of the
ODE can help to better distinguish which gene is firstly
expressed in a non-trivial scenario, such as the one pre-
sented in Figure 1b. In this example, we can see that it
is possible to infer the dynamic time order relation
between G1 and G2 only during the early time (because
only in the early time we observe a significant difference
between the two rates). By integrating the ODE (see
Equation (1)), the model can take into account all the
variation of the gene LCR (in early and late times). Note
that this dynamic time order relation does not imply
any causal relation between two genes but only indicates
which one is expressed after the other.
Natural cubic spline regression
In order to apply the integrated ODE model (Equation 2),
a smooth curve is required to fit gene expression over the
time. For this purpose, natural cubic spline regression
(NCSR) [17] represents a good choice, since it provides a
good trade-off between fit to data and model complexity.
NCSR is a third-order polynomial function:
fi(t) = β0 + β1 t + β2 t2 + β3 t3, (3)
with fi(t) the LCR of gene Gi. Observations yi for a
gene Gi are regressed by the NCSR function:
yi = β0 + β1 t + β2 t2 + β3 t3 + εSRi, (4)
with εSRi ∼ N (0, σ 2SRi) · εSRi and σ 2SRi respectively
denote the residuals of the spline regression and their
variance associated with the gene Gi.
The time interval of our gene expression data is t Î
[0; 32] hours. We divide the function fi into three parts
using two knots at 5.333 hours and 17.333 hours. The
decomposition of the cubic function using knots is pre-
sented in Additional file 1.
Let bij = (bij0, bij1, bij2, bij3)T and t = (1, t, t2, t3), then
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Figure 1 Logarithmic concentration ratios of two genes G1 and G2. a) A scenario showing a trivial order between the two genes. b) A more
complex scenario showing an non-trivial order.
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The parameters bij are learned by maximizing the likeli-
hood in Equation 6 with constrains (see Additional file 1).
There are 12 parameters in the cubic function. However,
only 4 out of the 12 parameters are free, as constrains
must be satisfied. If we set βTi2 = (βi20,βi21,βi22,βi23)
T as
the free parameters, we can solve parameters bi1 and bi3
(see Additional File 2).
We can simplify the joint likelihood in Equation 6 as
follows:
L(βi1, βi2, βi3, σ 2SRi|D) = (2πσ 2SRi)
−12
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1, t, t2, t3
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2 − 3K22 t +
3K2t3 − 288K2t2 + 9K32 t − 3K42
3K2 − 96
}
, (K2 ≤ t ≤ 32).
(8)
The maximum likelihood estimator of bi2 for gene Gi
can be computed through a multiple linear regression:
βˆ i2 = (T
∗TT∗)−1T∗Tyi, (9)
with T* a 12-by-4 matrix (presented in Additional
file 3). In the matrix T*, each row k corresponds to
the vector t* at the time point Tk of the vector
T T = (0, 1, 2, 4, 6, 8, 12, 16, 20, 24, 28, 32)T . As
previously mentioned, using the parameters βˆ i2 , we
can estimate the parameters βˆ i1 and βˆ i3 (see Addi-
tional file 2). Then with all these parameters, we can
obtain a smooth curve to represent fi(t) for gene Gi in
the whole time interval 0 to 32 hours, as Figure 2
shows for the gene APLP2. Therefore the ODE in
Equations 1 and 2 can be applied.
Time order determination
Based on Equation 2, the dynamic time order relation-
ship between two genes can be learned using the follow-
ing multiple linear regression:
yit = bi0 + bi1F1(t) + bi2F2(t) + εMRi, (10)
with εMRi ∼ N (0, σ 2MRi) · εMRi and σ 2MRi respectively
denote the residuals of the multiple regression and their
variance associated with gene Gi. The response variable
Figure 2 Gene expression of APLP2 fitted by natural cubic spline regression with 2 knots K1 and K2. K1 = 5.333 hours and K2 = 17.333
hours.
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yit is the LCR of gene Gi at time t and the predictor
variables are integrations of the cubic functions at time
t. For a predictor variable, the integration Fi of piecewise
cubic functions fi1, fi2 and fi3 is calculated as follows:
Fi(t) =
∫ t
0 fi1(t), (0 ≤ t < K1)
Fi(t) = C1 +
∫ t
K1
fi2(t), (K1 ≤ t < K2)
Fi(t) = C2 +
∫ t
K2





fi1(t) and C2 =
∫ K2
K1
fi2(t) + C1 are
constant terms. They vary for different gene LCRs.
We apply the model in Equation 10 to every pair of
genes to determine whether there is a dynamic time
order relation between them. The pairwise regression
models for two genes G1 and G2 are:
y1 = Xb1 + εMR1 (12)
y2 = Xb2 + εMR2, (13)
with εMRi ∼ N (0, σ 2MRi) . Vectors yT1 = (y10, . . . , y132)T
and yT2 = (y20, . . . , y232)
T are the LCRs for the pair of
genes G1 and G2, and bTi = (bi0, bi1, bi2)
T are the associ-
ate parameters in the model presented in Equation 10. Let
Fi(t) be the integration of fi(t) getting from Equation 11
and FTi = (Fi(0), . . . , Fi(32))
T be the function values for
Fi(t) at each time point t. Then the predictor variable is
X = (1, F1, F2).
Thus in Equations 12 and 13, values of yi (left hand
side) come from data and values of X (right hand side)
result from the integration of the NCSR functions. For
the pair of genes G1 and G2, the model in equation 12
represents the dynamic time order relation G2 ® G1
and the model in equation 13 represents the dynamic
time order relation G1 ® G2.
Pairwise regressions are then computed for all pairs of
genes and the log-likelihoods are calculated (see Addi-
tional file 4). In order to find whether a pair of genes
has a dynamic time order relation, we look at their log-
likelihood difference. If two genes present a dynamic
time order relation, the regression relying on the true
relation will have a better log-likelihood value than the
regression based on the wrong relation, as Equations 12
and 13 represent two different dynamic time orders.
Network construction
After determining the time order relationships, an n-by-
n adjacency matrix (n is the number of genes) is con-
structed whose weights are the previously computed
log-likelihood differences. In the matrix, for a couple of
genes, only the positive log-likelihood difference value is
kept and the negative (symmetric) log-likelihood differ-
ence value is set to 0. This adjacency matrix represents
the complete directed graph of time order relationships.
Small network
When the network is small (less than one hundred
nodes), it is interesting to keep as much as possible
information about time order relations. The best strat-
egy in this case is fine tune a threshold used to remove
non-significant edges. For this purpose, a simple and
efficient approach is the use of the median or other
quantiles of the distribution of log-likelihood difference
values. Then a simplification step is used to remove
Figure 3 Dynamic time order network and its biological interpretation. The blue nodes indicate the late response genes whereas the red
nodes point out the remaining genes.
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redundant edges. For instance, when one observes A ®
B and B ® C, then A ® C is considered as redundant
and is removed. For graph drawing, the Sugiyama’s algo-
rithm [18] provides a hierarchical display which is parti-
cularly relevant for reflecting time order relations.
Genome-wide network
When the network is huge, such as the genome-wide
network from the microarray data, the previous
approach cannot be used. The reason is that a low
threshold value will create a network highly connected
which is too complex to manipulate and to visualize,
whereas a high threshold value will lead to a graph with
many connected components from which it will only be
possible to infer time orders between connected genes.
To tackle this issue, we compute the so-called maxi-
mum weight spanning tree (MWST). This graph pre-
sents several advantages: (i) its tree shape is a very
simple structure easy to manipulate and visualize, and
(ii) every node is connected by a path such that we can
access to the time order relation between each gene.
Figure 4 Cell cycle temporal system modeling. a) The inferred dynamic time order network. b) A schematic representation of the cell cycle
temporal system [26]. The color code is the same as in Figure 3.
Figure 5 Genome-wide dynamic time order network. It has been computed for all the 5003 genes. Big circles represent incoming-edge hubs
at the center (blue) connected to a very large number of nodes (red). The color code is the same as in Figure 3.
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Besides, the MWST can be quickly computed in O
(n2logn) through the Prim’s algorithm [19]. Regarding
graph drawing, the Sugiyama’s algorithm cannot be used
when the graph is too huge. Instead we prefer to display
it using an algorithm specific to tree drawing, the Bub-
ble tree algorithm [20].
Biological interpretation of the model
The dynamic time order network (DTON) has a biologi-
cal interpretation. It is illustrated in Figure 3. In this
network, late response genes are hubs which are con-
nected by many incoming pathways. Thus the identifica-
tion of these hubs helps find candidates for biomarkers
of breast cancers. Based on this idea, we propose a cri-
terion to identify late response genes in the network.
Late response genes are defined as nodes only con-
nected to incoming edges, and the more incoming edges
a node has the later is considered its response. We call
these nodes “incoming-edge hubs”.
Implementation
Our learning method is implemented in R. The R source
code is available on request. For graph drawing and dis-
play, the software Tulip (http://tulip.labri.fr/TulipDrupal/)
was used. It is a user-friendly tool able to deal with about
one million nodes.
Results and discussion
Reproducing the cell cycle temporal system
The cell cycle temporal system represents a good bench-
mark for evaluating our method. In this subsection, in
order to see if we can reproduce the time order relations,
we focused on key cell cycle genes. Twelve mRNA
expression data were selected, which include cyclin A1
(CCNA1), cyclin A2 (CCNA2), cyclin B1 (CCNB1), cyclin
B2 (CCNB2), cyclin D1 (CCND1), cyclin D3 (CCND3),
cyclin E1 (CCNE1), cyclin E2 (CCNE2), cyclin-dependent
kinase 1 (CDK1), cyclin-dependent kinase 2 (CDK2),
cyclin-dependent kinase 4 (CDK4) and cyclin-dependent
kinase 6 (CDK6). Regressions have be computed for all
pairs of genes. Then, the network of cell cycle genes has
been computed by thresholding using the median of the
log-likelihood differences. After simplification, the
inferred network is composed of 27 time order relations.
It is depicted in Figure 4a. The reference network of cell
cycle genes is displayed in Figure 4b. Over the 27 time
order relations inferred, 24 correspond to the reference
network, 0 are wrong and 3 cannot be checked from the
reference network (because the reference network is not
enough accurate). The network is thus recovered with at
least 89% of accuracy. More notably, the network points
out 5 incoming-edge hubs: CDK2, CCNB2, CDK1,
CCNB1 and CCNA2 (these nodes are colored in blue in
Figure 4a). The genes CCNB2, CDK1, CCNB1 and
CCNA2 correspond to late response genes in the refer-
ence network. Regarding CDK2, it should be considered
as an intermediate response gene. Compared to the other
hubs which all show 5 incoming edges, CDK2 only pre-
sents 3 incoming edges.
Genome-wide network
For genome-wide network modeling, an MWST has been
constructed from all pairwise regressions on the 5003
genes. The network is depicted in Figure 5. We observe
that this network is composed of several large incoming-
edge hubs and reflects a star shape topology. The 10 most
important hubs are listed in Table 1. We observe that
CELCAM6 is connected to 2783 incoming edges (CEL-
CAM6 is magnified in the Figure 5). Other large hubs are
EPAS1, CALB2, UPK1A, KRT81, PDZK1, MT2A,
FANCD2, C20orf160 and WDR51A, in the decreasing
order of importance. The profiles of expression over time
are presented in Figure 6. All these profiles reflect a late
under- or overexpressed response. CELCAM6, EPAS1,
UPK1A and KRT81 are genes whose expressions decrease
over the time, whereas CALB2, PDZK1, MT2A, FANCD2,
C20orf160 and WDR51A are overexpressed after E2
treatment.
The identification of late response genes does not repre-
sent a well-studied issue. Most notably, no dedicated
method has been developed for this purpose. Nevertheless,
we tried to compare our method with standard approaches
in gene expression analysis: agglomerative hierarchical
clustering (AHC) and t-tests. On the one hand, AHC is a
well-used tool to cluster gene expression profiles. After
computing AHC, we used the silhouette criteria to deter-
mine the optimum number k of clusters [21]. We obtain
the best silhouette values for k = 5. However, when we
looked at the clusters, we were unable to identify any clus-
ter corresponding to late response genes. We thus tried
with higher values of k. With k = 20, we are able to more
accurately distinguish different trends in gene expression
Table 1 List of the 10 most important incoming-edge
hubs.
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(see Figure 7). However, it is still hard to identify late
response genes. The clusters 2 and 9 might represent can-
didates for over-expressed and under-expressed late
response genes, respectively. On the other hand, we used a
t-test strategy. We obtained better results. Our strategy
was the following: (i) first we selected genes whose devia-
tions of absolute LCR values from 0 for the first time
points 0, 1, 2, 4, 6, 8, 12 and 16 are non-significant (p -
Figure 6 Gene expression profiles for the 10 most important incoming-edge hubs. LCR: logarithmic concentration ratio.
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value >quantile(0.6)), and (ii) then, from these selected
genes, we only kept those whose absolute LCR values for
the last time points 20, 24, 28 and 32 are significantly
different from 0 (p - value <quantile(0.05)). Profiles of
selected genes are depicted in Figure 8. With t-tests we
observe a better identification of late response genes than
with AHC. However we notice that some of these gene
expressions oscillate between over- and under-expression
for the last time points. Figure 9 shows the Venn diagrams
for the comparison of results between DTON (our
method), the AHC and the t-test strategy. The t-test strat-
egy and DTON are both very specific with a few number
of genes identified: 91 and 27 over-expressed genes, and
13 and 8 under-expressed genes for t-tests and DTON,
respectively. For over-expressed genes, more than half of
the genes found with DTON are also identified with t-
tests. Regarding under-expressed genes, few genes are
shared. Comparatively, AHC is much less specific with
around 2600 over-expressed and around 200 under-
expressed genes. It is thus not surprising that AHC shares
Figure 7 Cluster profiles obtained with agglomerative hierarchical clustering, for all the 5003 genes.
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Figure 8 Profiles of late response genes identified using t-tests.
Figure 9 Venn diagram to compare the late response genes identified from the dynamic time order network (DTON), the
agglomerative hierarchical clustering (AHC) and the t-tests.
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a large proportion of over-expressed genes with DTON
and t-tests.
We also search in the literature if the late response
genes identified with our method can be good candidate
biomarkers. Since biomarkers are molecules that are
observed in cancer patients but not in healthly people,
there are likely to be genes overexpressed after E2 treat-
ment. Among the overexpressed hubs of the network,
CALB2, PDZK1, MT2A and FANCD2 are well-known
in the literature as diagnostic marker of breast cancer
and E2 response [22-25]. Besides, C20orf160 is reported
in the Genes-to-Systems Breast Cancer Database (http://
www.itb.cnr.it/breastcancer//index.html). WDR51A (also
called POC1A) is found associated with breast cancer in
The Human Protein Atlas (http://www.proteinatlas.org/).
Conclusion
Based on experimentations carried out on time-series
gene expression data, our dynamic time order network
has been shown to efficiently distinguish and connect
early and late response genes. First, our model has faith-
fully reproduced the cell cycle temporal system. Over
the 27 time order relations inferred, 89% correspond to
the state-of-art network, 11% cannot be checked, but no
one are false. Second, our approach has been success-
fully applied to a genome-wide level. The learning
method has been able to process five thousands genes
and the network simplification through the maximum
weighted spanning tree provided a graphical display of
the huge network. Most notably, several incoming-edge
hubs showing very high connectivity have been discov-
ered. All these hubs showed late gene response profiles.
Regarding those which are overexpressed over the time,
they have been reported as biomarkers of breast cancer
and E2 response in the literature and databases.
The comparison of results with other approaches is
not straightforward, since our method is the only one
dedicated to identify late response genes. When com-
pared with standard methods in gene expression analy-
sis, our approach yielded specific results, contrary to
agglomerative hierarchical clustering. Moreover it does
not need any complex thresholding such as with a t-test
strategy. It is worth noting that all genes identified with
DTON showed late responses, while this is not the case
with the t-test strategy. Besides, our approach is based
on the comparison of gene expression integrals com-
bined with cubic spline regression, thus offering an
accurate assessment of time order relations.
The discovery of biomarkers is one of the application
of our model. The distinction between early and late
response genes is also an important application in devel-
opmental biology where the understanding of the tem-
poral aspect of gene expression is a key issue such as
for cell differentiation. For the moment, we mainly
focused on the identification of late response genes. The
use of another graph modeling would be more efficient
for pointing out early response genes than the MWST
which tends to display incoming-edge hubs.
Additional material
Additional file 1: Decomposition of the cubic function using knots.
Additional file 2: Solving of parameters bi1 and bi3.
Additional file 3: Matrix T*.
Additional file 4: Likelihood computation of regression for the time
order determination.
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